Pixium Vision S.A.
OTC: PXMVF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Lloyd Diamond
- Employees
- 40
- Headquarters
- Paris, France
- IPO year
- 2021
- Market cap
- $4.6M
- Website
- https://www.pixium-vision.com
Loading PXMVF…
Loading profile data…Frequently asked questions about PXMVF
What does Pixium Vision S.A. (PXMVF) do?
Pixium Vision S.A., established in Paris, France, in 2011, is a pioneering firm specializing in bioelectronics and brain-machine interface technologies, with a particular emphasis on neuromodulation. The company's flagship product is the PRIMA System, an advanced bionic vision solution designed to restore sight for individuals experiencing profo...
Where does PXMVF trade?
Pixium Vision S.A. (PXMVF) trades on the Other OTC.
What sector is PXMVF in?
Pixium Vision S.A. (PXMVF) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Pixium Vision S.A.?
Lloyd Diamond is the chief executive officer of Pixium Vision S.A. (PXMVF).
Where is Pixium Vision S.A. headquartered?
Pixium Vision S.A. is headquartered in France.
Does PXMVF pay a dividend?
Pixium Vision S.A. (PXMVF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PXMVF go public?
Pixium Vision S.A. (PXMVF) completed its initial public offering in 2021.